Home / Hepatitis A, Inactivated, Whole Virus / Norway
NO ATC J07BC02 · updated 2 Nov 2026
Hepatitis A, Inactivated, Whole Virus shortage in Norway
Is there a Hepatitis A, Inactivated, Whole Virus shortage in Norway?
Yes. As of 2 Nov 2026, 1 Hepatitis A, Inactivated, Whole Virus product is reported short in Norway. The company estimate for the return is 31 Jan 2027. Main reason: increased demand.
Also short in Italy, Switzerland, Czechia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Havrix 1 440 ELISA E/ml injeksjonsvæske, suspensjon, 10 x 1 ml ferdigfylt sprøyte anticipated | GlaxoSmithKline AS | 4 Jan 2027 | 31 Jan 2027 | Increased demand Uventet økt etterspørsel |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).